Bluebird raising $211M; Alimera inks $50M financing deal;

@FierceBiotech: Cyclacel's cancer drug isn't working in Phase III, but that won't stop the trial. Story | Follow @FierceBiotech

@JohnCFierce: Top Monday story: UPDATED: Onyx vet Tony Coles embarks on a new biotech adventure. More | Follow @JohnCFierce

@DamianFierce: Scathing new ad for tightening regs on private equity. Story | Follow @DamianFierce

> Cambridge, MA-based bluebird bio ($BLUE) is raising $211 million through the sale of 2.6 million shares. Release

> Atlanta-based Alimera Sciences inked a $50 million financing deal with Deerfield. Release

Medical Device News

@FierceMedDev: ICYMI yesterday: FDA clears laser-based comb to combat hair loss. Article | Follow @FierceMedDev

@StacyALawrence: GE-backed InSightec gets $59M for noninvasive surgical tool, adds ex-Mako CEO to board. More | Follow @StacyALawrence

@EmilyWFierce: Power morcellator fallout illustrates major flaw in FDA's device regulation. WSJ story | Follow @EmilyWFierce

> Fresenius adds blood purification tech to its dialysis offerings via partnership. Article

> FDA took a back seat in morcellator regulation, researchers say. Report

Pharma News

@FiercePharma: New chief picks team to fuse Actavis with Allergan. Article | Follow @FiercePharma

@EricPFierce: ICYMI: Third round of cuts slated for Novartis US Diovan plant. Total reaches 133 with 394 more gone by 2016. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Baxter backs away from vaccines with Vero tech sale to Nanotherapeutics. More | Follow @CarlyHFierce

> Roche's Lucentis nabs FDA 'breakthrough' tag for diabetic eye disease. More

> FTC plows ahead in pay-for-delay suit over AbbVie's AndroGel. Article

> Fresh off Afinitor failure, Novartis turns tide with Signifor LAR approval. News

Pharma Manufacturing News

> Biocon to build new plant in Vizag, India. Report

> Industry Voices: The future of pharma manufacturing--new disruptive technologies that can impact whole industry structures. More

> Baxter has yet another recall of sodium chloride. News

> Teva continues to whittle down manufacturing network. Story

> Avid Bioservices doubling capacity at its California facility. Article

Biotech Research News

> Scientists look to a pathway in the gut to fix fatty liver disease. Piece

> Repurposed fibroblasts may open the door to new melanoma drugs, screening tech. More

> Investigators hit on a new class of stem cells. Item

> Joslin investigators urge cosmetics groups to get into anti-aging R&D. Article

> NIH's children's health study ends as a $1.2B disaster. Story

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.